Pilot Study on Immunotherapy for the Treatment of Persistant Peanut Allergy

Summary

The purpose of this trial is to assess the safety and efficacy of peanut immunotherapy in children and adults with peanut allergy. Participants will receive immunotherapy with peanut every 2 weeks for a period of 3 months.

Timeline

Start

2019-04-01

Primary completion

2022-04-19

Completion

2022-04-19

Outcome

Outcome not reported

Stopped (Enrollment): “early termination due to insufficient recruitment”

Drugs

Indications